Fundamental Analysis
74 / 100ARubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +63.1% | +47.6% | 2 / 3 | +7.0% | +2.74 pp | +1.84 pp | +21.3% | 0.47 | 6.92 | 1.147 | +7,0% | 61,5 | +63,1% | 6.92 | 7.41 | −6,6% |
| Pts | 12 | 12 | 8 | 0 | 8 | 8 | 12 | 12 | 8 | |||||||
Valuation annotation:Price: 53.000 (close price on 2026-10-19)EPS (TTM): 7.654
Financial charts
1.Revenue & growth
VND bn1.147Q2/26
1.Revenue & growth
VND bn1.147Q2/26
2.Profit & growth
VND bn61,5Q2/26
3.Profit mix (Penman)
VND bn251Q2/26
4.Margins & cost structure
%10.6%Q2/26
5.Returns & cash cycle
% · days18.5%Q2/26
6.Earnings quality & cash
VND bn33,6Q2/26
7.Asset structure
VND bn1.894Q2/26
8.Funding & debt health
VND bn · times1.894Q2/26
9.Revenue backlog
VND bn0,00Q2/26
10.Valuation
times · %6,9×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %2.347Q2/26
Adjusted EPS growth, latest quarter
63.1%
Average adjusted EPS growth, 3 quarters
47.6%
Quarters at 25%+ growth
2/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26